Try our Advanced Search for more refined results
July 17, 2006
Track this case
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
A New Jersey federal judge on Tuesday preliminarily approved an $8.1 million settlement in a securities class action alleging Par Pharmaceutical Cos. misled investors and overstated its revenue by at least $55 million.
Already a subscriber? Click here to login